UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use

PloS one, 2011-07, Vol.6 (7), p.e22020-e22020

2011

Volltextzugriff (PDF)

Prevention of Vaginal SHIV Transmission in Rhesus Macaques through Inhibition of CCR5

Science (American Association for the Advancement of Science), 2004-10, Vol.306 (5695), p.485-487

2004

Volltextzugriff (PDF)

Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching

Journal of Virology, 2004-07, Vol.78 (14), p.7565-7574

2004

Volltextzugriff (PDF)

Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism

Journal of Virology, 2011-10, Vol.85 (20), p.10669-10681

2011

Volltextzugriff (PDF)

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

Journal of Virology, 2012-09, Vol.86 (18), p.10218-10220

2012

Volltextzugriff (PDF)

Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region

Genetics (Austin), 2010-05, Vol.185 (1), p.293-303

2010

Volltextzugriff (PDF)

Evolution of CCR5 Use before and during Coreceptor Switching

Journal of Virology, 2008-12, Vol.82 (23), p.11758-11766

2008

Volltextzugriff (PDF)

Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo

Immunity (Cambridge, Mass.), 1999-04, Vol.10 (4), p.431-438

1999

Volltextzugriff (PDF)

Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES

Antimicrobial Agents and Chemotherapy, 2003-02, Vol.47 (2), p.509-517

2003

Volltextzugriff (PDF)

Conserved Changes in Envelope Function during Human Immunodeficiency Virus Type 1 Coreceptor Switching

Journal of Virology, 2007-08, Vol.81 (15), p.8165-8179

2007

Volltextzugriff (PDF)

Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C

Journal of acquired immune deficiency syndromes (1999), 2011-01, Vol.56 (1), p.9

2011

Volltextzugriff (PDF)

How HIV changes its tropism: evolution and adaptation?

Current opinion in HIV & AIDS, 2009-03, Vol.4 (2), p.125

Mosier, Donald E

2009

Volltextzugriff (PDF)

Evolution of CXCR4-Using Human Immunodeficiency Virus Type 1 SF162 Is Associated with Two Unique Envelope Mutations

Journal of Virology, 2007-04, Vol.81 (7), p.3657-3661

2007

Volltextzugriff (PDF)

Transduction of Human CD34$^+$ Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors

Science (American Association for the Advancement of Science), 1999-01, Vol.283 (5402), p.682-686

1999

Volltextzugriff (PDF)

Whither or Wither Microbicides?

Science (American Association for the Advancement of Science), 2008-07, Vol.321 (5888), p.532-534

2008

Volltextzugriff (PDF)

The Story Behind "A Requirement for Two Cell Types for Antibody Formation in vitro"

Frontiers in immunology, 2014, Vol.5, p.495-495

Mosier, Donald E

2014

Volltextzugriff (PDF)

HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry

AIDS (London), 2007-03, Vol.21 (6), p.693-702

2007

Volltextzugriff (PDF)

High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia

AIDS research and human retroviruses, 2017-03, Vol.33 (3), p.234

2017

Volltextzugriff (PDF)

Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins

Scientific reports, 2013-10, Vol.3 (1), p.3014-3014, Article 3014

2013

Volltextzugriff (PDF)

Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Gag- and Gag Peptide-Specific CD4+ T-Cell Clones from an HIV-1-Seronegative Donor following In Vitro Immunization

Journal of Virology, 2002-07, Vol.76 (14), p.6987-6999

2002

Volltextzugriff (PDF)

Human Immunodeficiency Virus Infection of Human-PBL-SCID Mice

Science (American Association for the Advancement of Science), 1991-02, Vol.251 (4995), p.791-794

1991

Volltextzugriff (PDF)

Inhibition of RNA Polymerase II Transcription in Human Cells by Synthetic DNA-Binding Ligands

Proceedings of the National Academy of Sciences - PNAS, 1998-10, Vol.95 (22), p.12890-12895

1998

Volltextzugriff (PDF)

Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants

Journal of Virology, 1999-05, Vol.73 (5), p.3544-3550

1999

Volltextzugriff (PDF)

“Resistance” to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

Journal of Virology, 2010-06, Vol.84 (11), p.5842-5845

2010

Volltextzugriff (PDF)

"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance

Journal of virology, 2010-06, Vol.84 (11), p.5842-5845

2010

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(116)
Buchkapitel
(11)
Reviews
(1)

Sprache

Englisch
(128)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Animals
(68)
Humans
(66)
Life Sciences & Biomedicine
(66)
Mice
(63)
Aids/hiv
(41)
Immunology
(38)
Biological And Medical Sciences
(34)
Virology
(29)
Mice, Scid
(26)
Medical Sciences
(24)
Hiv-1 - Physiology
(19)
Hiv Infections - Immunology
(17)
Human Immunodeficiency Virus 1
(17)
Disease Models, Animal
(16)
Infectious Diseases
(16)
Human Immunodeficiency Virus
(15)
Molecular Sequence Data
(15)
Female
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use

Prevention of Vaginal SHIV Transmission in Rhesus Macaques through Inhibition of CCR5

Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching

Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region

Evolution of CCR5 Use before and during Coreceptor Switching

Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo

Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES

Conserved Changes in Envelope Function during Human Immunodeficiency Virus Type 1 Coreceptor Switching

Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C

How HIV changes its tropism: evolution and adaptation?

Evolution of CXCR4-Using Human Immunodeficiency Virus Type 1 SF162 Is Associated with Two Unique Envelope Mutations

Transduction of Human CD34$^+$ Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors

Whither or Wither Microbicides?

The Story Behind "A Requirement for Two Cell Types for Antibody Formation in vitro"

HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry

High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia

Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins

Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Gag- and Gag Peptide-Specific CD4+ T-Cell Clones from an HIV-1-Seronegative Donor following In Vitro Immunization

Human Immunodeficiency Virus Infection of Human-PBL-SCID Mice

Inhibition of RNA Polymerase II Transcription in Human Cells by Synthetic DNA-Binding Ligands

Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants

“Resistance” to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance

Suchergebnisse filtern